共 146 条
[1]
Ramroth J(2016)Dose and fractionation in radiation therapy of curative intent for non-small cell lung cancer: meta-analysis of randomized trials Int J Radiat Oncol Biol Phys 96 736-747
[2]
Cutter D(2015)Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study Lancet Oncol 16 187-199
[3]
Darby S(2017)The impact of cardiac radiation dosimetry on survival after radiation therapy for non-small cell lung cancer Int J Radiat Oncol Biol Phys 99 51-60
[4]
Higgins G(2017)Radiation dose to heart base linked with poorer survival in lung cancer patients Eur J Cancer 85 106-113
[5]
McGale P(2018)Cardiac dose is associated with immunosuppression and poor survival in locally advanced non-small cell lung cancer Radiother Oncol 128 498-504
[6]
Partridge M(2017)The relationship between cardiac radiation dose and mediastinal lymph node involvement in stage III non-small cell lung cancer patients Adv Radiat Oncol 2 192-196
[7]
Bradley J(2016)Normal tissue considerations and dose–volume constraints in the moderately hypofractionated treatment of non-small cell lung cancer Radiother Oncol 119 423-431
[8]
Paulus R(2016)IDEAL-CRT: A phase 1/2 trial of isotoxic dose-escalated radiation therapy and concurrent chemotherapy in patients with stage II/III non-small cell lung cancer Int J Radiat Oncol Biol Phys 95 1367-1377
[9]
Komaki R(2013)Risk of ischemic heart disease in women after radiotherapy for breast cancer N Engl J Med 368 987-998
[10]
Masters G(2017)Cardiac events after radiation therapy: combined analysis of prospective multicenter trials for locally advanced non-small-cell lung cancer J Clin Oncol 35 1395-1402